<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T03:55:59Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6732557" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6732557</identifier>
        <datestamp>2019-09-12</datestamp>
        <setSpec>jintaidssoc</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Int AIDS Soc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Int AIDS Soc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)1758-2652</journal-id>
              <journal-id journal-id-type="publisher-id">JIA2</journal-id>
              <journal-title-group>
                <journal-title>Journal of the International AIDS Society</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1758-2652</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6732557</article-id>
              <article-id pub-id-type="pmcid">PMC6732557</article-id>
              <article-id pub-id-type="pmc-uid">6732557</article-id>
              <article-id pub-id-type="pmid">31496051</article-id>
              <article-id pub-id-type="doi">10.1002/jia2.25376</article-id>
              <article-id pub-id-type="publisher-id">JIA225376</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Research Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI‐PMTCT study</article-title>
                <alt-title alt-title-type="left-running-head">Yotebieng M et al.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jia225376-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Yotebieng</surname>
                    <given-names>Marcel</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2110-2631</contrib-id>
                  <address>
                    <email>myotebieng@gmail.com</email>
                  </address>
                  <xref ref-type="aff" rid="jia225376-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225376-cr-0002" contrib-type="author">
                  <name>
                    <surname>Mpody</surname>
                    <given-names>Christian</given-names>
                  </name>
                  <xref ref-type="aff" rid="jia225376-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225376-cr-0003" contrib-type="author">
                  <name>
                    <surname>Ravelomanana</surname>
                    <given-names>Noro LR</given-names>
                  </name>
                  <xref ref-type="aff" rid="jia225376-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jia225376-cr-0004" contrib-type="author">
                  <name>
                    <surname>Tabala</surname>
                    <given-names>Martine</given-names>
                  </name>
                  <xref ref-type="aff" rid="jia225376-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jia225376-cr-0005" contrib-type="author">
                  <name>
                    <surname>Malongo</surname>
                    <given-names>Fathy</given-names>
                  </name>
                  <xref ref-type="aff" rid="jia225376-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jia225376-cr-0006" contrib-type="author">
                  <name>
                    <surname>Kawende</surname>
                    <given-names>Bienvenu</given-names>
                  </name>
                  <xref ref-type="aff" rid="jia225376-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jia225376-cr-0007" contrib-type="author">
                  <name>
                    <surname>Ntangu</surname>
                    <given-names>Paul</given-names>
                  </name>
                  <xref ref-type="aff" rid="jia225376-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jia225376-cr-0008" contrib-type="author">
                  <name>
                    <surname>Behets</surname>
                    <given-names>Frieda</given-names>
                  </name>
                  <xref ref-type="aff" rid="jia225376-aff-0004">
                    <sup>4</sup>
                  </xref>
                  <xref ref-type="aff" rid="jia225376-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jia225376-cr-0009" contrib-type="author">
                  <name>
                    <surname>Okitolonda</surname>
                    <given-names>Emile</given-names>
                  </name>
                  <xref ref-type="aff" rid="jia225376-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jia225376-cr-0010" contrib-type="author">
                  <collab collab-type="authors">for the CQI‐PMTCT study team</collab>
                </contrib>
              </contrib-group>
              <aff id="jia225376-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Division of Epidemiology</named-content>
                <named-content content-type="organisation-division">College of Public Health</named-content>
                <institution>The Ohio State University</institution>
                <named-content content-type="city">Columbus</named-content>
                <named-content content-type="country-part">OH</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jia225376-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">School of Public Health</named-content>
                <institution>The University of Kinshasa</institution>
                <named-content content-type="city">Kinshasa</named-content>
                <named-content content-type="country-part">Democratic Republic of Congo</named-content>
              </aff>
              <aff id="jia225376-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">National AIDS Control Program (PNLS)</named-content>
                <institution>Provincial Coordination</institution>
                <named-content content-type="city">Kinshasa</named-content>
                <named-content content-type="country-part">Democratic Republic of Congo</named-content>
              </aff>
              <aff id="jia225376-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Epidemiology</named-content>
                <named-content content-type="organisation-division">Gillings School of Global Public Health</named-content>
                <institution>The University of North Carolina at Chapel Hill</institution>
                <named-content content-type="city">Chapel Hill</named-content>
                <named-content content-type="country-part">NC</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jia225376-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Department of Social Medicine</named-content>
                <institution>The University of North Carolina at Chapel Hill</institution>
                <named-content content-type="city">Chapel Hill</named-content>
                <named-content content-type="country-part">NC</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Corresponding author:</bold> Marcel Yotebieng, The Ohio State University, College of Public Health, Division of Epidemiology, Columbus, Ohio, USA. Tel: +1 718 920 2564. (<email>myotebieng@gmail.com</email>; <email>yotebieng.2@osu.edu</email>)</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>08</day>
                <month>9</month>
                <year>2019</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>9</month>
                <year>2019</year>
              </pub-date>
              <volume>22</volume>
              <issue>9</issue>
              <issue-id pub-id-type="doi">10.1002/jia2.v22.9</issue-id>
              <elocation-id>e25376</elocation-id>
              <history>
                <date date-type="received">
                  <day>26</day>
                  <month>2</month>
                  <year>2019</year>
                </date>
                <date date-type="accepted">
                  <day>21</day>
                  <month>7</month>
                  <year>2019</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2019 International AIDS Society <copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2019 The Authors. Journal of the International AIDS Society published by John Wiley &amp; Sons Ltd on behalf of the International AIDS Society.</copyright-statement>
                <license license-type="creativeCommonsBy">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:JIA2-22-e25376.pdf"/>
              <abstract id="jia225376-abs-0001">
                <title>Abstract</title>
                <sec id="jia225376-sec-0001">
                  <title>Introduction</title>
                  <p>Published data on viral suppression among pregnant and breastfeeding women in routine care settings are scarce. Here, we report provincial estimates of undetectable and suppressed viral load among pregnant or breastfeeding women in HIV care in Kinshasa, Democratic Republic of Congo (DRC) and associated risk factors.</p>
                </sec>
                <sec id="jia225376-sec-0002">
                  <title>Methods</title>
                  <p>This cross‐sectional study was conducted as part of a baseline assessment for the CQI‐PMTCT study: an ongoing cluster randomized trial to evaluate the effect of continuous quality interventions (CQI) on long‐term ART outcomes among pregnant and breastfeeding women (NCT03048669). From November 2016 to June 2018, in each of the 35 Kinshasa provincial health zones (HZ), study teams visited the three busiest maternal and child health clinics, enrolled all HIV‐positive pregnant or breastfeeding women (≤1 year post‐delivery) receiving ART, and performed viral load testing. Log binomial models with generalized estimating equations to account for clustering at the HZ level, were used to estimate prevalence ratios comparing participants with undetected (&lt;40 copies/mL) or suppressed (&lt;1000 copies/mL) viral load across levels of individual and site characteristics.</p>
                </sec>
                <sec id="jia225376-sec-0003">
                  <title>Results</title>
                  <p>Of the 1752 eligible women, 1623 had viral load results available, including 38% who had been on ART for &lt;6 months and 74% were on tenofovir‐lamivudine‐efavirenz. Viral load was undetectable in 53% of women and suppressed in 62%. Among women who were on ART for ≥12 months, only 60% and 67% respectively, had undetectable or suppressed viral load. Viral load was undetectable in 53%, 48% and 58% of women testing during pregnancy, at delivery, and in postpartum respectively. In multivariable log binomial models, duration of ART &gt;12 months, older age, being married, disclosure of HIV status, receiving care in an urban health zone or one supported by PEPFAR were all positively associated with viral suppression.</p>
                </sec>
                <sec id="jia225376-sec-0004">
                  <title>Conclusions</title>
                  <p>The observed high level of detectable viral load suggests that high ART coverage alone without substantial efforts to improve the quality of care for pregnant and breastfeeding women, will not be enough to achieve the goal of virtual elimination of vertical HIV transmission in high‐burden and limited resources settings like DRC.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jia225376-kwd-0001">pregnant women</kwd>
                <kwd id="jia225376-kwd-0002">option B+</kwd>
                <kwd id="jia225376-kwd-0003">treat all</kwd>
                <kwd id="jia225376-kwd-0004">universal coverage</kwd>
                <kwd id="jia225376-kwd-0005">viral suppression</kwd>
                <kwd id="jia225376-kwd-0006">vertical transmission</kwd>
                <kwd id="jia225376-kwd-0007">viral load monitoring</kwd>
                <kwd id="jia225376-kwd-0008">quality of care</kwd>
                <kwd id="jia225376-kwd-0009">
                  <styled-content style="fixed-case">HIV</styled-content>
                </kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>President's Emergency Plan for AIDS Relief (PEPFAR)</funding-source>
                </award-group>
                <award-group>
                  <funding-source>National Institute of Health and Child Development</funding-source>
                  <award-id>1R01H087993</award-id>
                </award-group>
                <award-group>
                  <funding-source>National Institutes of Health</funding-source>
                  <award-id>U01AI096299</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="4"/>
                <table-count count="3"/>
                <page-count count="12"/>
                <word-count count="8846"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>component-id</meta-name>
                  <meta-value>jia225376</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>September 2019</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.8 mode:remove_FC converted:09.09.2019</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="jia225376-cit-1001"><string-name><surname>Yotebieng</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Mpody</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Ravelomanana</surname>, <given-names>N. L. R.</given-names></string-name>, <string-name><surname>Tabala</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Malongo</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Kawende</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Ntangu</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Behets</surname>, <given-names>F.</given-names></string-name> and <string-name><surname>Okitolonda</surname>, <given-names>E.</given-names></string-name>
<article-title>HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI‐PMTCT study</article-title>. <source xml:lang="en">J Int AIDS Soc</source>. <year>2019</year>; <volume>22</volume>(<issue>9</issue>):<elocation-id>e25376</elocation-id>
</mixed-citation>
              </p>
            </notes>
          </front>
          <body>
            <sec id="jia225376-sec-0005">
              <label>1</label>
              <title>Introduction</title>
              <p>Spurred by the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive, new paediatric HIV infections were reduced by 60%, between 2009 and 2015, in the 21 countries in sub‐Saharan Africa with the highest burden <xref rid="jia225376-bib-0001" ref-type="ref">1</xref>. Galvanized by such progress, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), launched in 2016 the <italic>Start Free, Stay Free, AIDS Free</italic> initiative with super‐fast‐track target of reducing the number of newly infected children to less than 40 000 by 2018 and 20 000 by 2020 <xref rid="jia225376-bib-0002" ref-type="ref">2</xref>. To achieve this ambitious target, 95% of pregnant women living with HIV (PWLHIV) must be reached and sustained on lifelong antiretroviral therapy (ART) in 21 sub‐Saharan African countries which together with India and Indonesia, account for about 90% of new paediatric infections <xref rid="jia225376-bib-0002" ref-type="ref">2</xref>.</p>
              <p>Although UNAIDS monitors and regularly publishes updated ART coverage and estimates of viral suppression <xref rid="jia225376-bib-0003" ref-type="ref">3</xref>, population based studies on viral suppression (i.e. third 90) among PWLHIV are limited <xref rid="jia225376-bib-0004" ref-type="ref">4</xref>. Yet, in addition to the high rate of loss to follow‐up among PWLHIV <xref rid="jia225376-bib-0005" ref-type="ref">5</xref>, adherence to ART among those retained in care is known to be sub‐optimal, particularly in the postpartum period <xref rid="jia225376-bib-0006" ref-type="ref">6</xref>, <xref rid="jia225376-bib-0007" ref-type="ref">7</xref>. In a pooled analysis of 51 studies involving 20,153 PWLHIV mostly from United States, Kenya, South Africa and Zambia, 75.7% of participants had adequate (≥80%) ART adherence during pregnancy compared with 53.0% in the postpartum <xref rid="jia225376-bib-0008" ref-type="ref">8</xref>. Similarly, in an analysis of data from women who initiated ART during pregnancy and breastfeeding from 13 large health facilities in Malawi between September 2011 and October 2013, about 70% were found to have adequate (&gt;90% of days covered by pharmacy claims) adherence during the first two years of ART. However, only about 30% of them maintained adequate adherence at every visit <xref rid="jia225376-bib-0009" ref-type="ref">9</xref>. A recent report from South Africa showed that, even after viral suppression had been achieved, only about 70% of women were able to maintain viral suppression throughout a median follow‐up time of 322 days <xref rid="jia225376-bib-0010" ref-type="ref">10</xref>. Because routine monitoring of viral load is limited in most of the 21 priority countries in sub‐Saharan Africa, to the best of our knowledge there has been no attempt outside of targeted cohort studies, to estimate the proportion of pregnant and breastfeeding women with viral suppression in routine ART care.</p>
              <p>The aims of this study were to 1) estimate the proportion of pregnant and breastfeeding women receiving routine HIV care in maternal and child health (MCH) clinics in the Kinshasa province of the Democratic Republic of Congo (DRC) with undetectable (&lt;40 copies/mL) or suppressed (&lt;1000 copies/mL) viral load and 2) assess socio‐demographic, clinical and health facility characteristics associated with undetectable and suppressed viral load.</p>
            </sec>
            <sec id="jia225376-sec-0006">
              <label>2</label>
              <title>Methods</title>
              <sec id="jia225376-sec-0007">
                <label>2.1</label>
                <title>Study design and settings</title>
                <p>This cross‐sectional study was conducted as part of baseline assessment for the CQI‐PMTCT study: an ongoing cluster randomized trial to evaluate the effect of continuous quality interventions (CQI) on long‐term outcome of ART among pregnant and breastfeeding women (NCT03048669) <xref rid="jia225376-bib-0011" ref-type="ref">11</xref>. Briefly, Health zones were randomized to data driven quality improvement group in which multidisciplinary teams are brought together quarterly to identify key bottlenecks in care delivery system, develop and implement plans to address the bottlenecks at the district or facility levels. The protocol with detailed description of the intervention has been published elsewhere <xref rid="jia225376-bib-0011" ref-type="ref">11</xref>.</p>
                <p>DRC is one of the <italic>Start Free, Stay Free, AIDS Free</italic> priority countries <xref rid="jia225376-bib-0002" ref-type="ref">2</xref>. Roughly nine in ten pregnant women in DRC attend at least one antenatal care (ANC) visit, surpassing 97% in Kinshasa <xref rid="jia225376-bib-0012" ref-type="ref">12</xref>. Starting in October 2013 and with support from PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria, DRC has been progressively scaling‐up Option B+ (ART for life to all HIV‐positive pregnant women) <xref rid="jia225376-bib-0013" ref-type="ref">13</xref>. In Kinshasa, all pregnant women with unknown HIV status registering for antenatal care or presenting for delivery are offered an HIV test (acceptance rate &gt; 97%) and those who test positive are immediately initiated on a triple antiretroviral combination. After delivery, mother‐infant pairs are followed up at MCH facilities until 24 months or the cessation of breastfeeding or until the mother (and the child if HIV positive) is transferred to HIV clinics for continued HIV care. Viral load measurement is accessible at the national reference laboratory in downtown Kinshasa at a subsidized cost of $25 or at higher cost per test at two other facilities and is recommended for every patient on ART at least once a year.</p>
              </sec>
              <sec id="jia225376-sec-0008">
                <label>2.2</label>
                <title>Study population and data collection</title>
                <p>From a list of MCH facilities providing services to prevent mother‐to‐child transmission of HIV (PMTCT) obtained from the National Program for the Fight against AIDS (PNLS), we selected the busiest three in terms of number of PWLHV served during 2015 in each of the 35 health zones of the Kinshasa province (Figure <xref rid="jia225376-fig-0001" ref-type="fig">1</xref>).</p>
                <p>Between June and November 2016, study staff visited each selected health facility to collect information on the facility characteristics using a structured questionnaire. Following the facility survey, starting November 2016, all pregnant or breastfeeding women living with HIV receiving care in selected facilities were identified using medical records, approached during routine clinic visits and invited to participate in the study. Participants could be enrolled at any time during pregnancy, immediately after delivery (in the maternity ward during the one to three days post‐delivery observation), or during well‐child visits in postpartum period. Eligible women who were not on ART, no longer breastfeeding, or whose infants were more than 12 months old were excluded. After obtaining written informed consent, a structured questionnaire was used to collect participant's socio‐demographic and clinical information.</p>
              </sec>
              <sec id="jia225376-sec-0009">
                <label>2.3</label>
                <title>Viral load testing</title>
                <p>For participants who agreed to provide a blood specimen, five spots of 50 mL of blood were obtained via a finger prick on Whatman paper. The collected blood spots were then dried at ambient temperature for at least three hours. The dried blood samples (DBS) were then packaged with desiccant and stored at −20°C until testing at the National AIDS Reference Laboratory in Kinshasa (LNRS). LNRS proceeds samples on the basis of first come, first served, meaning it may take weeks or sometime months for results to become available. The median time between sample collection and availability of results was 72 days. Viral load testing was conducted using m2000rt Real‐Time HIV‐1 assay (Abbott, Chicago, IL), with a detection limit of 40 copies/mL. The LNRS laboratory received technical support including external quality assurance <xref rid="jia225376-bib-0014" ref-type="ref">14</xref>.</p>
              </sec>
              <sec id="jia225376-sec-0010">
                <label>2.4</label>
                <title>Variables</title>
                <p>The primary outcomes in this study were viral suppression defined as viral load &lt;1000 copies/mL and undetectable viral load or viral load &lt;40 copies/mL. Other variables of interest included facility and participant demographic and clinical characteristics. Facility characteristics included: location (urban vs. peri‐urban/rural), PEPFAR funding support for HIV care (Yes vs. No), type (hospital vs. health centre). Participant demographic and clinical characteristics included: maternal age in years (≤ 24, 25 to 34, or 35+), marital status (married/ cohabitating vs. divorced/separated/widowed/never married), timing of HIV diagnosis (prior to current pregnancy vs. during current pregnancy), duration of treatment in months (&lt;6, 6 to 12, 12 to 24, or 24+), educational level (primary, secondary or tertiary), usual mode of commute to the clinic (walking vs. other), disclosure of HIV status to anyone (yes vs. no), primigravida (no vs. yes), timing of viral load testing (pregnancy, immediately after delivery, or post‐partum) and a wealth index score used as a proxy of socioeconomic status (SES). The wealth index score was obtained, as in previous manuscripts <xref rid="jia225376-bib-0015" ref-type="ref">15</xref>, <xref rid="jia225376-bib-0016" ref-type="ref">16</xref>, from principal components analysis of the following factors: years of education (in years), average number of household members per room, number of sleeping beds in the household, type of household water source (communal vs. private pipe), cooking fuel type (electrical stove vs. wood/charcoal) and ownership status (yes vs. no) for several household's goods (mobile phone, radio, fridge, vehicle, bike and motorcycle). The first component explained 20.7% of variability in the dataset and was categorized into quintiles: 0 (lowest SES), 1, 2, 3 and 4 (highest SES). The duration of ART was calculated using the date of ART initiation extracted from participants’ medical records. When the date was not available in clinic records, participants were asked to estimate about how long they have been on ART.</p>
              </sec>
              <sec id="jia225376-sec-0011">
                <label>2.5</label>
                <title>Statistical analysis</title>
                <p>The proportion of women with viral suppression (viral load &lt;1000 copies/mL) <xref rid="jia225376-bib-0013" ref-type="ref">13</xref> and undetectable viral load were estimated by time of enrolment: during pregnancy, immediately after delivery and postpartum. Bivariable and multivariable log binomial models were used to estimate the prevalence ratio (PR) and 95% confidence interval (95% CI) as measure of the strength of the association between health facility, sociodemographic and clinical characteristics with viral suppression. When the log binomial did not converge, Poisson regression modelling was used. Generalized estimating equation was used in all models to account for potential clustering at the level of health zone or possible extra Poisson variance. Only facility and individual characteristics found to be statistically associated with viral suppression in bivariable analysis (alpha = 0.2) were included in multivariable models <xref rid="jia225376-bib-0017" ref-type="ref">17</xref>. All statistical analyses were conducted using Stata Version 14.0 and all statistical tests were two‐sided with an alpha level of 0.05 except when otherwise indicated.</p>
                <p>The study was approved by the University of Kinshasa School of Public Health Ethical Review Committee and the Ohio State University Institutional Review Board. All participants provided written inform consent.</p>
              </sec>
            </sec>
            <sec id="jia225376-sec-0012">
              <label>3</label>
              <title>Results</title>
              <sec id="jia225376-sec-0013">
                <label>3.1</label>
                <title>Participants characteristics</title>
                <p>By 30 June 2018, when the database was closed for this analysis, 1752 potential participants had been assessed for participation in the study, of whom 1742 met eligibility criteria and 1717 were enrolled. Viral load results were available for 1623 women (Figure <xref rid="jia225376-fig-0002" ref-type="fig">2</xref>).</p>
                <fig fig-type="Figure" xml:lang="en" id="jia225376-fig-0001" orientation="portrait" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>Map and characteristics of enrolment sites.</p>
                  </caption>
                  <graphic id="nlm-graphic-1" xlink:href="JIA2-22-e25376-g001"/>
                </fig>
                <p>Table <xref rid="jia225376-tbl-0001" ref-type="table">1</xref> summarizes the distribution of facility and individual characteristics of 1623 participants included in this analysis. Over half (56%, n = 914) of women were enrolled in hospitals as opposed to health centres; 62% (n = 1012) in health facilities supported by PEPFAR; and 93% (n = 1510) in facilities located in urban areas.</p>
                <table-wrap id="jia225376-tbl-0001" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>Socio‐demographic and clinical characteristics of 1623 women living with HIV from 105 clinics in Kinshasa tested for HIV viral load between November 2016 and July 2018<xref ref-type="fn" rid="jia225376-note-0002">a</xref>
</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">Characteristics</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">No %<xref ref-type="fn" rid="jia225376-note-0002">b</xref>
</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Timing of viral load testing</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pregnancy</td>
                        <td align="left" rowspan="1" colspan="1">873 (54)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Delivery</td>
                        <td align="left" rowspan="1" colspan="1">378 (23)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Post‐partum</td>
                        <td align="left" rowspan="1" colspan="1">378 (23)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Location of health facility (where participant was recruited)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Peri‐urban/rural</td>
                        <td align="left" rowspan="1" colspan="1">113 (7)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Urban</td>
                        <td align="left" rowspan="1" colspan="1">1510 (93)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">PEPFAR funding of facility</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">611 (38)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td>
                        <td align="left" rowspan="1" colspan="1">1012 (62)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Type of facility</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Health centre</td>
                        <td align="left" rowspan="1" colspan="1">709 (44)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hospital</td>
                        <td align="left" rowspan="1" colspan="1">914 (56)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Time on ART (median [IQR])</td>
                        <td align="left" rowspan="1" colspan="1">17 [2, 46]</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">&lt;6 months</td>
                        <td align="left" rowspan="1" colspan="1">602 (38)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">6 to 11 months</td>
                        <td align="left" rowspan="1" colspan="1">119 (8)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">12 to 24 months</td>
                        <td align="left" rowspan="1" colspan="1">176 (11)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">&gt;24 months</td>
                        <td align="left" rowspan="1" colspan="1">679 (43)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Marital status</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Divorced/separated/ widowed/never married</td>
                        <td align="left" rowspan="1" colspan="1">511 (32)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Married/cohabitating</td>
                        <td align="left" rowspan="1" colspan="1">1078 (68)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Maternal age in years (median [IQR])</td>
                        <td align="left" rowspan="1" colspan="1">32 [27, 36]</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">≤24</td>
                        <td align="left" rowspan="1" colspan="1">239 (15)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">25 to 34</td>
                        <td align="left" rowspan="1" colspan="1">848 (53)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">35+</td>
                        <td align="left" rowspan="1" colspan="1">502 (32)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Disclosure of HIV status<xref ref-type="fn" rid="jia225376-note-0002">c</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">787 (49)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td>
                        <td align="left" rowspan="1" colspan="1">826 (51)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">ART regimen</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">TDF + 3TC+FEV</td>
                        <td align="left" rowspan="1" colspan="1">1208 (74)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">AZT + 3TC+NVP</td>
                        <td align="left" rowspan="1" colspan="1">207 (13)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Other</td>
                        <td align="left" rowspan="1" colspan="1">208 (13)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Mode of transport to the clinic</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Walking</td>
                        <td align="left" rowspan="1" colspan="1">601 (38)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Taxi/other</td>
                        <td align="left" rowspan="1" colspan="1">988 (62)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Primigravida</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td>
                        <td align="left" rowspan="1" colspan="1">145 (9)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">1445 (91)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">Educational level</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Primary</td>
                        <td align="left" rowspan="1" colspan="1">221 (14)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Secondary</td>
                        <td align="left" rowspan="1" colspan="1">1118 (70)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Tertiary</td>
                        <td align="left" rowspan="1" colspan="1">249 (16)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="2" rowspan="1">SES in quintile<xref ref-type="fn" rid="jia225376-note-0002">d</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">0 (Lowest)</td>
                        <td align="left" rowspan="1" colspan="1">295 (21)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">274 (19)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">2</td>
                        <td align="left" rowspan="1" colspan="1">289 (20)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">3</td>
                        <td align="left" rowspan="1" colspan="1">271 (19)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">4 (Highest)</td>
                        <td align="left" rowspan="1" colspan="1">297 (21)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jia225376-note-0001">
                      <p>ART, antiretroviral therapy; SES, socio‐economic status.</p>
                    </fn>
                    <fn id="jia225376-note-0002">
                      <p><sup>a</sup>The analytical sample was derived from the enrolment data of an ongoing cluster randomized controlled trial, aimed at evaluating the effect of data‐driven continuous quality improvement on long‐term ART outcomes in Kinshasa, Democratic Republic of Congo; <sup>b</sup>frequencies might not add up to the total for the category, because of missing data; <sup>c</sup>self‐report of disclosure of HIV status to anyone; <sup>d</sup>calculated using principal component analysis and categorized in five quintile groups.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <p>The median age of participants was 32 (Interquartile range (IQR) 27 to 36) with 15% (n = 239) of women aged 24 years or younger and 53% (n = 848) aged 25 to 34 years. Most participants (68%, n = 1078) were married or cohabiting, 14% (n = 211) had completed less than primary school and 16% (n = 249) had at least some tertiary education; and 38% (n = 601) reported walking to their clinic.</p>
                <p>Overall, 54% (n = 873) were surveyed during pregnancy and 23% (n = 378) immediately following delivery (one to three days after); 74% (n = 1208) of participants were on tenofovir‐lamivudine‐efavirenz, 13% (n = 207) on zidovudine‐lamivudine‐nevirapine, and the remaining were on less common regimens or did not know what regimen they were on. The median duration on ART was 17 months (IQR 2 to 46; range 0 to 162). Over a third (38%, n = 602) have been on ART for &lt;6 months.</p>
              </sec>
              <sec id="jia225376-sec-0014">
                <label>3.2</label>
                <title>Proportion of participants with viral suppression or undetectable viral load</title>
                <p>Overall, 62% (n = 1000; 95% CI 59% to 64%) and 53% (n = 858; 95% CI 50% to 55%) of women had suppressed or undetectable viral load respectively (Figure <xref rid="jia225376-fig-0003" ref-type="fig">3</xref>). The proportion with viral suppression or undetectable viral load varied greatly by health zones, ranging from 37% in Maluku I to 84% in Gombe for suppressed viral load or from 26% in Maluku I to 64% in Bandalungwa or Kalumu I for undetectable viral load (Figure <xref rid="jia225376-fig-0004" ref-type="fig">4</xref> and Table <xref rid="jia225376-sup-0001" ref-type="supplementary-material">S3</xref>). Viral suppression and undetectable viral load also varied slightly by duration on ART with 54% (328/602) and 44%(265/602) of women on ART less than six months achieving viral suppression and undetectable viral load respectively, compared with 61%(72/119) and 50% (60/119) of women on ART between six and eleven months, 67%(118/176) and 60% (105/176) of women on ART between 12 and 24 months, and 67% (456/679) and 59% (403/679) of women on ART longer than 24 months (Figure <xref rid="jia225376-fig-0002" ref-type="fig">2</xref>).</p>
                <fig fig-type="Figure" xml:lang="en" id="jia225376-fig-0002" orientation="portrait" position="float">
                  <label>Figure 2</label>
                  <caption>
                    <p>Participants recruitment flowchart. *Other reasons include hearing impairment of participant, intent of participant to transfer to a different clinic, false pregnancy.</p>
                  </caption>
                  <graphic id="nlm-graphic-3" xlink:href="JIA2-22-e25376-g002"/>
                </fig>
                <fig fig-type="Figure" xml:lang="en" id="jia225376-fig-0003" orientation="portrait" position="float">
                  <label>Figure 3</label>
                  <caption>
                    <p>(a) Proportion of the 1623 women with viral load &lt;1000 and &lt;40 copies/mL by duration of ART. (b) Proportion of the 1623 women with viral load &lt;1000 and &lt;40 copies/mL by timing of sample collection.</p>
                  </caption>
                  <graphic id="nlm-graphic-5" xlink:href="JIA2-22-e25376-g003"/>
                </fig>
              </sec>
              <sec id="jia225376-sec-0015">
                <label>3.3</label>
                <title>Association of facility and individual characteristics with viral suppression</title>
                <p>Table <xref rid="jia225376-tbl-0002" ref-type="table">2</xref> summarizes the results of bivariable analysis. Overall, women receiving care in PEPFAR supported facilities were more likely to have viral load &lt;1000 copies/mL compared to their counterparts in non‐PEPFAR supported clinics (PR 1.10; 95% CI 1.00 to 1.21). This association was strongest among breastfeeding women in postpartum period (PR 1.18; 95% CI 1.04 to 1.35). Similarly, receiving care in a hospital as opposed to health centre was statistically associated with viral suppression (PR 1.10; 95% CI 1.00 to 1.22) during pregnancy, but not at any other time. Longer duration of ART was also associated with achieving viral suppression among women enrolled during pregnancy or immediately after delivery but tended to be negatively associated with viral suppression among those enrolled in postpartum. Older or married/cohabiting women were all more likely to achieve viral suppression as were those reporting taxi/other as the primary mode of commute to the clinic as opposed to walking. Disclosure of HIV status to anyone was also positively and statistically associated with viral suppression during pregnancy and immediately after delivery, but not in the postpartum period. Similar associations were found for undetectable viral load (Table <xref rid="jia225376-sup-0001" ref-type="supplementary-material">S1</xref>).</p>
                <table-wrap id="jia225376-tbl-0002" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <p>Bivariable associations between facilities’, socio‐demographic and clinical characteristics and viral load &lt;1000 copies/mL by timing of HIV viral load testing<xref ref-type="fn" rid="jia225376-note-0004">a</xref>
</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="3" valign="top" colspan="1">Characteristics</th>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">All women (1623)</th>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Pregnant women (873)</th>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Parturient women (378)</th>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" valign="top" rowspan="1">Breastfeeding mothers (378)</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1">n/N (%)<xref ref-type="fn" rid="jia225376-note-0004">b</xref>
</th>
                        <th align="left" rowspan="2" valign="top" colspan="1">uPR (95% CI)<xref ref-type="fn" rid="jia225376-note-0004">c</xref>
</th>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1">n/N (%)<xref ref-type="fn" rid="jia225376-note-0004">b</xref>
</th>
                        <th align="left" rowspan="2" valign="top" colspan="1">uPR(95% CI)<xref ref-type="fn" rid="jia225376-note-0004">c</xref>
</th>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1">n/N (%)<xref ref-type="fn" rid="jia225376-note-0004">b</xref>
</th>
                        <th align="left" rowspan="2" valign="top" colspan="1">uPR(95% CI)<xref ref-type="fn" rid="jia225376-note-0004">c</xref>
</th>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1">n/N (%)<xref ref-type="fn" rid="jia225376-note-0004">b</xref>
</th>
                        <th align="left" rowspan="2" valign="top" colspan="1">uPR(95% CI)<xref ref-type="fn" rid="jia225376-note-0004">c</xref>
</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">VL &lt;1000 copies/mL</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">VL &lt;1000 copies/mL</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">VL &lt;1000 copies/mL</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">VL &lt;1000 copies/mL</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Location of facility attended<xref ref-type="fn" rid="jia225376-note-0004">d</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Peri‐urban/Rural</td>
                        <td align="left" rowspan="1" colspan="1">59/113 (52)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">29/56 (52)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">17/27 (63)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">13/30 (43)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Urban</td>
                        <td align="left" rowspan="1" colspan="1">941/1510 (62)</td>
                        <td align="left" rowspan="1" colspan="1">1.19 (0.94, 1.51)</td>
                        <td align="left" rowspan="1" colspan="1">513/817 (63)</td>
                        <td align="left" rowspan="1" colspan="1">1.21 (0.98, 1.50)</td>
                        <td align="left" rowspan="1" colspan="1">195/345 (57)</td>
                        <td align="left" rowspan="1" colspan="1">0.90 (0.63, 1.29)</td>
                        <td align="left" rowspan="1" colspan="1">233/348 (67)</td>
                        <td align="left" rowspan="1" colspan="1">1.54 (0.90, 2.65)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">PEPFAR funding of facility</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">353/611 (58)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">208/349 (60)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">69/133 (52)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">76/129 (59)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td>
                        <td align="left" rowspan="1" colspan="1">647/1012 (64)</td>
                        <td align="left" rowspan="1" colspan="1">1.10 (1.00, 1.21)</td>
                        <td align="left" rowspan="1" colspan="1">334/524 (64)</td>
                        <td align="left" rowspan="1" colspan="1">1.07 (0.96, 1.20)</td>
                        <td align="left" rowspan="1" colspan="1">143/239 (60)</td>
                        <td align="left" rowspan="1" colspan="1">1.14 (0.92, 1.42)</td>
                        <td align="left" rowspan="1" colspan="1">170/249 (68)</td>
                        <td align="left" rowspan="1" colspan="1">1.18 (1.04, 1.35)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Type of facility</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Health centre</td>
                        <td align="left" rowspan="1" colspan="1">418/709 (59)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">233/399 (58)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">75/142 (53)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">110/168 (65)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hospital</td>
                        <td align="left" rowspan="1" colspan="1">582/914 (64)</td>
                        <td align="left" rowspan="1" colspan="1">1.10 (1.00, 1.22)</td>
                        <td align="left" rowspan="1" colspan="1">309/474 (65)</td>
                        <td align="left" rowspan="1" colspan="1">1.11 (1.00, 1.24)</td>
                        <td align="left" rowspan="1" colspan="1">137/230 (60)</td>
                        <td align="left" rowspan="1" colspan="1">1.15 (0.92, 1.45)</td>
                        <td align="left" rowspan="1" colspan="1">136/210 (65)</td>
                        <td align="left" rowspan="1" colspan="1">0.99 (0.85, 1.15)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Time on ART</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">&lt;6 months</td>
                        <td align="left" rowspan="1" colspan="1">328/602 (54)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">207/384 (54)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">74/152 (49)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">47/66 (71)</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">6 to 11 months</td>
                        <td align="left" rowspan="1" colspan="1">72/119 (61)</td>
                        <td align="left" rowspan="1" colspan="1">1.11 (0.93, 1.32)</td>
                        <td align="left" rowspan="1" colspan="1">26/36 (72)</td>
                        <td align="left" rowspan="1" colspan="1">1.34 (1.08, 1.67)</td>
                        <td align="left" rowspan="1" colspan="1">15/23 (65)</td>
                        <td align="left" rowspan="1" colspan="1">1.34 (0.99, 1.81)</td>
                        <td align="left" rowspan="1" colspan="1">31/60 (52)</td>
                        <td align="left" rowspan="1" colspan="1">0.73 (0.59, 0.89)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">12 to 24 months</td>
                        <td align="left" rowspan="1" colspan="1">118/176 (67)</td>
                        <td align="left" rowspan="1" colspan="1">1.23 (1.07, 1.42)</td>
                        <td align="left" rowspan="1" colspan="1">54/81 (67)</td>
                        <td align="left" rowspan="1" colspan="1">1.24 (1.05, 1.46)</td>
                        <td align="left" rowspan="1" colspan="1">28/39 (72)</td>
                        <td align="left" rowspan="1" colspan="1">1.48 (1.07, 2.06)</td>
                        <td align="left" rowspan="1" colspan="1">36/56 (64)</td>
                        <td align="left" rowspan="1" colspan="1">0.90 (0.73, 1.11)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">&gt;24 months</td>
                        <td align="left" rowspan="1" colspan="1">456/679 (67)</td>
                        <td align="left" rowspan="1" colspan="1">1.23 (1.13, 1.34)</td>
                        <td align="left" rowspan="1" colspan="1">252/365 (69)</td>
                        <td align="left" rowspan="1" colspan="1">1.28 (1.17, 1.40)</td>
                        <td align="left" rowspan="1" colspan="1">86/140 (61)</td>
                        <td align="left" rowspan="1" colspan="1">1.26 (1.02, 1.56)</td>
                        <td align="left" rowspan="1" colspan="1">118/174 (68)</td>
                        <td align="left" rowspan="1" colspan="1">0.95 (0.79, 1.14)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Marital status</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Divorced/separated/widowed/never married</td>
                        <td align="left" rowspan="1" colspan="1">289/511 (57)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">158/272 (58)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">60/115 (52)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">71/124 (57)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Married/cohabitating</td>
                        <td align="left" rowspan="1" colspan="1">691/1078 (64)</td>
                        <td align="left" rowspan="1" colspan="1">1.14 (1.05, 1.25)</td>
                        <td align="left" rowspan="1" colspan="1">384/600 (64)</td>
                        <td align="left" rowspan="1" colspan="1">1.10 (0.99, 1.23)</td>
                        <td align="left" rowspan="1" colspan="1">145/244 (59)</td>
                        <td align="left" rowspan="1" colspan="1">1.14 (0.91, 1.43)</td>
                        <td align="left" rowspan="1" colspan="1">162/234 (69)</td>
                        <td align="left" rowspan="1" colspan="1">1.21 (1.04, 1.41)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Maternal age in years</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">≤24</td>
                        <td align="left" rowspan="1" colspan="1">123/239 (51)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">66/128 (52)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">31/60 (52)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">26/51 (51)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">25 to 34</td>
                        <td align="left" rowspan="1" colspan="1">516/848 (61)</td>
                        <td align="left" rowspan="1" colspan="1">1.18 (1.02, 1.36)</td>
                        <td align="left" rowspan="1" colspan="1">306/492 (62)</td>
                        <td align="left" rowspan="1" colspan="1">1.21 (1.00, 1.45)</td>
                        <td align="left" rowspan="1" colspan="1">87/173 (50)</td>
                        <td align="left" rowspan="1" colspan="1">0.97 (0.67, 1.39)</td>
                        <td align="left" rowspan="1" colspan="1">123/183 (67)</td>
                        <td align="left" rowspan="1" colspan="1">1.32 (1.01, 1.73)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">35+</td>
                        <td align="left" rowspan="1" colspan="1">341/502 (68)</td>
                        <td align="left" rowspan="1" colspan="1">1.31 (1.14, 1.51)</td>
                        <td align="left" rowspan="1" colspan="1">170/252 (67)</td>
                        <td align="left" rowspan="1" colspan="1">1.31 (1.10, 1.57)</td>
                        <td align="left" rowspan="1" colspan="1">87/126 (69)</td>
                        <td align="left" rowspan="1" colspan="1">1.33 (0.99, 1.79)</td>
                        <td align="left" rowspan="1" colspan="1">84/124 (68)</td>
                        <td align="left" rowspan="1" colspan="1">1.33 (1.02, 1.74)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Disclosure of HIV status<xref ref-type="fn" rid="jia225376-note-0004">e</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">437/787 (56)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">228/426 (54)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">93/193 (48)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">116/168 (69)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td>
                        <td align="left" rowspan="1" colspan="1">556/826 (67)</td>
                        <td align="left" rowspan="1" colspan="1">1.21 (1.12, 1.30)</td>
                        <td align="left" rowspan="1" colspan="1">313/446 (70)</td>
                        <td align="left" rowspan="1" colspan="1">1.31 (1.19, 1.44)</td>
                        <td align="left" rowspan="1" colspan="1">119/179 (66)</td>
                        <td align="left" rowspan="1" colspan="1">1.38 (1.13, 1.68)</td>
                        <td align="left" rowspan="1" colspan="1">124/201 (62)</td>
                        <td align="left" rowspan="1" colspan="1">0.89 (0.77, 1.04)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">ART regimen</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">TDF + 3TC+FEV</td>
                        <td align="left" rowspan="1" colspan="1">746/1208 (62)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">410/660 (62)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">174/293 (59)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">162/255 (64)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">AZT + 3TC+NVP</td>
                        <td align="left" rowspan="1" colspan="1">132/207 (64)</td>
                        <td align="left" rowspan="1" colspan="1">1.04 (0.93, 1.17)</td>
                        <td align="left" rowspan="1" colspan="1">79/120 (66)</td>
                        <td align="left" rowspan="1" colspan="1">1.06 (0.91, 1.24)</td>
                        <td align="left" rowspan="1" colspan="1">13/28 (46)</td>
                        <td align="left" rowspan="1" colspan="1">0.78 (0.53, 1.13)</td>
                        <td align="left" rowspan="1" colspan="1">40/59 (68)</td>
                        <td align="left" rowspan="1" colspan="1">1.07 (0.89, 1.28)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Other</td>
                        <td align="left" rowspan="1" colspan="1">122/208 (59)</td>
                        <td align="left" rowspan="1" colspan="1">0.95 (0.84, 1.07)</td>
                        <td align="left" rowspan="1" colspan="1">53/93 (57)</td>
                        <td align="left" rowspan="1" colspan="1">0.92 (0.75, 1.12)</td>
                        <td align="left" rowspan="1" colspan="1">25/51 (49)</td>
                        <td align="left" rowspan="1" colspan="1">0.84 (0.64, 1.10)</td>
                        <td align="left" rowspan="1" colspan="1">44/64 (69)</td>
                        <td align="left" rowspan="1" colspan="1">1.08 (0.91, 1.29)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Mode of transport to the clinic</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Walking</td>
                        <td align="left" rowspan="1" colspan="1">353/601 (59)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">197/332 (59)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">78/140 (56)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">78/129 (60)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Taxi/other</td>
                        <td align="left" rowspan="1" colspan="1">627/988 (63)</td>
                        <td align="left" rowspan="1" colspan="1">1.07 (0.98, 1.16)</td>
                        <td align="left" rowspan="1" colspan="1">345/541 (64)</td>
                        <td align="left" rowspan="1" colspan="1">1.08 (0.96, 1.21)</td>
                        <td align="left" rowspan="1" colspan="1">127/218 (58)</td>
                        <td align="left" rowspan="1" colspan="1">1.04 (0.85, 1.27)</td>
                        <td align="left" rowspan="1" colspan="1">78/129 (60)</td>
                        <td align="left" rowspan="1" colspan="1">1.13 (0.95, 1.35)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Primigravida</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td>
                        <td align="left" rowspan="1" colspan="1">86/145 (59)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">50/86 (58)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">18/36 (50)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">18/23 (78)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">894/1445 (62)</td>
                        <td align="left" rowspan="1" colspan="1">1.04 (0.90, 1.21)</td>
                        <td align="left" rowspan="1" colspan="1">492/787 (63)</td>
                        <td align="left" rowspan="1" colspan="1">1.08 (0.88, 1.31)</td>
                        <td align="left" rowspan="1" colspan="1">187/323 (58)</td>
                        <td align="left" rowspan="1" colspan="1">1.16 (0.85, 1.57)</td>
                        <td align="left" rowspan="1" colspan="1">215/335 (64)</td>
                        <td align="left" rowspan="1" colspan="1">0.82 (0.66, 1.01)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Alcohol consumption</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">&gt;4 times/month</td>
                        <td align="left" rowspan="1" colspan="1">60/95 (63)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">31/55 (56)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">17/26 (65)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">12/14 (86)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">1 to 3 times/month</td>
                        <td align="left" rowspan="1" colspan="1">216/357 (61)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">131/207 (63)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">44/81 (54)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">41/69 (59)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">704/1137 (62)</td>
                        <td align="left" rowspan="1" colspan="1">1.02 (0.95, 1.10)</td>
                        <td align="left" rowspan="1" colspan="1">380/610 (62)</td>
                        <td align="left" rowspan="1" colspan="1">1.02 (0.95, 1.10)</td>
                        <td align="left" rowspan="1" colspan="1">144/252 (57)</td>
                        <td align="left" rowspan="1" colspan="1">1.01 (0.91, 1.11)</td>
                        <td align="left" rowspan="1" colspan="1">180/275 (66)</td>
                        <td align="left" rowspan="1" colspan="1">1.01 (0.84, 1.22)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">Educational level</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Primary</td>
                        <td align="left" rowspan="1" colspan="1">136/221 (62)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">70/111 (63)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">30/55 (55)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">36/55 (65)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Secondary</td>
                        <td align="left" rowspan="1" colspan="1">686/1118 (61)</td>
                        <td align="left" rowspan="1" colspan="1">1.00 (0.88, 1.13)</td>
                        <td align="left" rowspan="1" colspan="1">374/601 (62)</td>
                        <td align="left" rowspan="1" colspan="1">0.99 (0.84, 1.16)</td>
                        <td align="left" rowspan="1" colspan="1">146/254 (57)</td>
                        <td align="left" rowspan="1" colspan="1">1.06 (0.84, 1.32)</td>
                        <td align="left" rowspan="1" colspan="1">166/263 (63)</td>
                        <td align="left" rowspan="1" colspan="1">0.96 (0.78, 1.19)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Tertiary</td>
                        <td align="left" rowspan="1" colspan="1">157/249 (63)</td>
                        <td align="left" rowspan="1" colspan="1">1.02 (0.88, 1.19)</td>
                        <td align="left" rowspan="1" colspan="1">98/160 (61)</td>
                        <td align="left" rowspan="1" colspan="1">0.97 (0.81, 1.17)</td>
                        <td align="left" rowspan="1" colspan="1">28/49 (57)</td>
                        <td align="left" rowspan="1" colspan="1">1.06 (0.77, 1.46)</td>
                        <td align="left" rowspan="1" colspan="1">31/40 (78)</td>
                        <td align="left" rowspan="1" colspan="1">1.18 (0.92, 1.52)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="9" rowspan="1">SES in quintile<xref ref-type="fn" rid="jia225376-note-0004">f</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">0 (Lowest)</td>
                        <td align="left" rowspan="1" colspan="1">175/295 (59)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">90/155 (58)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">33/60 (55)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">52/80 (65)</td>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">168/274 (61)</td>
                        <td align="left" rowspan="1" colspan="1">1.04 (0.92, 1.18)</td>
                        <td align="left" rowspan="1" colspan="1">89/147 (61)</td>
                        <td align="left" rowspan="1" colspan="1">1.04 (0.87, 1.25)</td>
                        <td align="left" rowspan="1" colspan="1">36/62 (58)</td>
                        <td align="left" rowspan="1" colspan="1">1.07 (0.75, 1.54)</td>
                        <td align="left" rowspan="1" colspan="1">43/65 (66)</td>
                        <td align="left" rowspan="1" colspan="1">1.02 (0.84, 1.23)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">2</td>
                        <td align="left" rowspan="1" colspan="1">186/289 (64)</td>
                        <td align="left" rowspan="1" colspan="1">1.08 (0.94, 1.25)</td>
                        <td align="left" rowspan="1" colspan="1">114/173 (66)</td>
                        <td align="left" rowspan="1" colspan="1">1.13 (0.95, 1.35)</td>
                        <td align="left" rowspan="1" colspan="1">41/70 (59)</td>
                        <td align="left" rowspan="1" colspan="1">1.08 (0.75, 1.55)</td>
                        <td align="left" rowspan="1" colspan="1">31/46 (67)</td>
                        <td align="left" rowspan="1" colspan="1">1.03 (0.82, 1.31)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">3</td>
                        <td align="left" rowspan="1" colspan="1">161/271 (59)</td>
                        <td align="left" rowspan="1" colspan="1">1.00 (0.85, 1.18)</td>
                        <td align="left" rowspan="1" colspan="1">112/181 (62)</td>
                        <td align="left" rowspan="1" colspan="1">1.07 (0.90, 1.26)</td>
                        <td align="left" rowspan="1" colspan="1">23/46 (50)</td>
                        <td align="left" rowspan="1" colspan="1">0.93 (0.57, 1.52)</td>
                        <td align="left" rowspan="1" colspan="1">26/44 (59)</td>
                        <td align="left" rowspan="1" colspan="1">0.90 (0.67, 1.21)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">4 (Highest)</td>
                        <td align="left" rowspan="1" colspan="1">193/297 (65)</td>
                        <td align="left" rowspan="1" colspan="1">1.10 (0.97, 1.24)</td>
                        <td align="left" rowspan="1" colspan="1">126/198 (64)</td>
                        <td align="left" rowspan="1" colspan="1">1.10 (0.93, 1.29)</td>
                        <td align="left" rowspan="1" colspan="1">37/53 (70)</td>
                        <td align="left" rowspan="1" colspan="1">1.30 (0.98, 1.72)</td>
                        <td align="left" rowspan="1" colspan="1">30/46 (65)</td>
                        <td align="left" rowspan="1" colspan="1">1.00 (0.77, 1.30)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jia225376-note-0003">
                      <p>ART, antiretroviral therapy; CI, confidence interval; SES, socio‐economic status; uPR, unadjusted prevalence ratio; VL, viral load.</p>
                    </fn>
                    <fn id="jia225376-note-0004">
                      <p><sup>a</sup>The analytical sample was derived from the enrolment data of an ongoing cluster randomized controlled trial, aimed at evaluating the effect of data‐driven continuous quality improvement on long‐term ART outcomes in Kinshasa, Democratic Republic of Congo; <sup>b</sup>frequencies might not add up to the total for the category, because of missing data. Percentages are for rows; <sup>c</sup>estimated by log binomial models, where general estimating equation was used to adjust for within health zone clustering; <sup>d</sup>facility at which participants were enrolled; <sup>e</sup>self‐reported disclosure of HIV status to anyone; <sup>f</sup>calculated using principal component analysis and categorized in five quintile groups.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
                <p>In a multivariable analysis that included the location and type of facility, source of international funding/support, duration of ART, age, disclosure of HIV status, marital status, and mode of transport to clinic, the results did not change substantially (Table <xref rid="jia225376-tbl-0003" ref-type="table">3</xref>). Among breastfeeding women, receiving care in a PEPFAR supported clinic remained statistically associated with viral suppression: aPR 1.17; 95% CI 1.02, 1.34 respectively. Disclosure of HIV status remained associated with viral suppression among pregnant women and those surveyed immediately after delivery: aPR 1.23; 95% CI 1.11, 1.36 and 1.39; 95% CI 1.16, 1.66 respectively. Despite not statistically significant, disclosure of HIV status and not walking to the clinic were both negatively associated with viral suppression among breastfeeding women (aPR 0.88; 95% CI 0.75, 1.02). Using &lt;40 copies/mL as cut‐off did not change the results substantially (Table <xref rid="jia225376-sup-0001" ref-type="supplementary-material">S2</xref>).</p>
                <table-wrap id="jia225376-tbl-0003" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 3</label>
                  <caption>
                    <p>Multivariable associations between facility's, socio‐demographic and clinical characteristics and viral load &lt;1000 copies/mL, by timing of viral load testing<xref ref-type="fn" rid="jia225376-note-0006">a</xref>
</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <col style="border-right:solid 1px #000000" span="1"/>
                    <thead valign="top">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" valign="top" colspan="1">Baseline covariates</th>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1">All women (1623)</th>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1">Pregnant women (873)</th>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1">Parturient women (378)</th>
                        <th align="left" style="border-bottom:solid 1px #000000" valign="top" rowspan="1" colspan="1">Breastfeeding mothers (378)</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="top" rowspan="1" colspan="1">APR<xref ref-type="fn" rid="jia225376-note-0006">b</xref> (95% CI)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">APR<xref ref-type="fn" rid="jia225376-note-0006">b</xref> (95% CI)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">APR<xref ref-type="fn" rid="jia225376-note-0006">b</xref> (95% CI)</th>
                        <th align="left" valign="top" rowspan="1" colspan="1">aPR<xref ref-type="fn" rid="jia225376-note-0006">b</xref> (95% CI)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Location of facility<xref ref-type="fn" rid="jia225376-note-0006">c</xref> attended</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Peri‐urban/rural</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Urban</td>
                        <td align="left" rowspan="1" colspan="1">1.24 (1.00, 1.54)</td>
                        <td align="left" rowspan="1" colspan="1">1.26 (1.00, 1.59)</td>
                        <td align="left" rowspan="1" colspan="1">1.04 (0.78, 1.39)</td>
                        <td align="left" rowspan="1" colspan="1">1.50 (0.86, 2.59)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Type of facility</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Health centre</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hospital</td>
                        <td align="left" rowspan="1" colspan="1">1.05 (0.97, 1.15)</td>
                        <td align="left" rowspan="1" colspan="1">1.09 (1.00, 1.19)</td>
                        <td align="left" rowspan="1" colspan="1">1.16 (0.96, 1.41)</td>
                        <td align="left" rowspan="1" colspan="1">0.97 (0.87, 1.08)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">PEPFAR funding of facility </td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td>
                        <td align="left" rowspan="1" colspan="1">1.09 (1.00, 1.19)</td>
                        <td align="left" rowspan="1" colspan="1">1.07 (0.96, 1.18)</td>
                        <td align="left" rowspan="1" colspan="1">1.14 (0.92, 1.41)</td>
                        <td align="left" rowspan="1" colspan="1">1.17 (1.02, 1.34)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Time on ART</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">&lt;6 months</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">6 to 11 months</td>
                        <td align="left" rowspan="1" colspan="1">1.07 (0.91, 1.27)</td>
                        <td align="left" rowspan="1" colspan="1">1.28 (1.05, 1.56)</td>
                        <td align="left" rowspan="1" colspan="1">1.19 (0.81, 1.75)</td>
                        <td align="left" rowspan="1" colspan="1">0.73 (0.59, 0.90)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">12 to 24 months</td>
                        <td align="left" rowspan="1" colspan="1">1.19 (1.03, 1.37)</td>
                        <td align="left" rowspan="1" colspan="1">1.15 (0.97, 1.36)</td>
                        <td align="left" rowspan="1" colspan="1">1.42 (1.12, 1.81)</td>
                        <td align="left" rowspan="1" colspan="1">0.90 (0.70, 1.15)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">&gt;24 months</td>
                        <td align="left" rowspan="1" colspan="1">1.14 (1.02, 1.27)</td>
                        <td align="left" rowspan="1" colspan="1">1.18 (1.04, 1.33)</td>
                        <td align="left" rowspan="1" colspan="1">1.05 (0.86, 1.27)</td>
                        <td align="left" rowspan="1" colspan="1">0.94 (0.79, 1.11)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Maternal age in years</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">≤24</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">25 to 34</td>
                        <td align="left" rowspan="1" colspan="1">1.11 (0.96, 1.28)</td>
                        <td align="left" rowspan="1" colspan="1">1.12 (0.92, 1.35)</td>
                        <td align="left" rowspan="1" colspan="1">0.86 (0.60, 1.23)</td>
                        <td align="left" rowspan="1" colspan="1">1.22 (0.94, 1.58)</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">35+</td>
                        <td align="left" rowspan="1" colspan="1">1.21 (1.05, 1.39)</td>
                        <td align="left" rowspan="1" colspan="1">1.17 (0.97, 1.41)</td>
                        <td align="left" rowspan="1" colspan="1">1.17 (0.85, 1.66)</td>
                        <td align="left" rowspan="1" colspan="1">1.28 (0.98, 1.66)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Disclosure of HIV status<xref ref-type="fn" rid="jia225376-note-0006">d</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">No</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Yes</td>
                        <td align="left" rowspan="1" colspan="1">1.15 (1.07, 1.25)</td>
                        <td align="left" rowspan="1" colspan="1">1.23 (1.11, 1.36)</td>
                        <td align="left" rowspan="1" colspan="1">1.39 (1.16, 1.66)</td>
                        <td align="left" rowspan="1" colspan="1">0.88 (0.75, 1.02)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Marital status</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Divorced/separated/widowed/never married</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Married/cohabitating</td>
                        <td align="left" rowspan="1" colspan="1">1.09 (1.00, 1.19)</td>
                        <td align="left" rowspan="1" colspan="1">1.06 (0.95, 1.18)</td>
                        <td align="left" rowspan="1" colspan="1">1.12 (0.90, 1.39)</td>
                        <td align="left" rowspan="1" colspan="1">1.12 (0.98, 1.29)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="5" rowspan="1">Mode of transport to the clinic</td>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Walking</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1">1</td>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Taxi/other</td>
                        <td align="left" rowspan="1" colspan="1">1.00 (0.91, 1.08)</td>
                        <td align="left" rowspan="1" colspan="1">0.98 (0.87, 1.10)</td>
                        <td align="left" rowspan="1" colspan="1">0.89 (0.73, 1.07)</td>
                        <td align="left" rowspan="1" colspan="1">1.08 (0.91, 1.30)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="jia225376-note-0005">
                      <p>aPR, adjusted prevalence ratio; ART, antiretroviral therapy; VL, viral load.</p>
                    </fn>
                    <fn id="jia225376-note-0006">
                      <p><sup>a</sup>The analytical sample was derived from the enrolment data of an ongoing cluster randomized controlled trial, aimed at evaluating the effect of data‐driven continuous quality improvement on long‐term ART outcomes in Kinshasa, Democratic Republic of Congo. We retained participants that had available data on HIV viral load testing; <sup>b</sup>estimated by log binomial models, adjusted for all covariates in the table, and where general estimating equation was used to adjust for within health zone clustering; <sup>c</sup>facility at which participants attend PMTCT visits; <sup>d</sup>self‐reported disclosure of HIV status to anyone.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
            </sec>
            <sec id="jia225376-sec-0016">
              <label>4</label>
              <title>Discussion</title>
              <p>To the best of our knowledge, this is the first study that aimed at estimating viral suppression at the population level among pregnant and breastfeeding women in routine HIV care. Our results show that, in the city‐province of Kinshasa in DRC, only 62% and 53% of pregnant and breastfeeding women living with HIV and in care, had viral load &lt;1000 and &lt;40 copies/mL respectively. Even among women who had been on ART longer than 12 months, the proportion with viral load &lt;1000 or &lt;40 copies/mL only increased to 67% or 60% respectively. Given the known tendency of DBS compared to plasma samples to systematically underestimate viral load <xref rid="jia225376-bib-0018" ref-type="ref">18</xref>, the true proportion of women with suppressed viral load is probably even lower.</p>
              <fig fig-type="Figure" xml:lang="en" id="jia225376-fig-0004" orientation="portrait" position="float">
                <label>Figure 4</label>
                <caption>
                  <p>Proportion of participants with viral load &lt;1000 and &lt;40 copies/mL by health zone in Kinshasa.</p>
                </caption>
                <graphic id="nlm-graphic-7" xlink:href="JIA2-22-e25376-g004"/>
              </fig>
              <p>The <italic>Start Free, Stay Free, AIDS Free</italic> ambitious target of reducing new paediatric HIV infection to 20,000 by 2020 is based on the premise that at least 95% of PWLHIV who are on ART will achieve and sustain suppressed viral load during pregnancy, delivery and throughout the breastfeeding period <xref rid="jia225376-bib-0002" ref-type="ref">2</xref>. Data on viral load among pregnant and breastfeeding women in sub‐Saharan Africa are limited and mostly come from study cohorts, principally from South Africa. In a cohort of newly diagnosed pregnant women, enrolled in the control arm of an intervention study before 28 weeks of gestation in some of the same clinics participating in the current study, 70% had undetectable viral load at six weeks postpartum although only 78% were on ART at enrolment <xref rid="jia225376-bib-0007" ref-type="ref">7</xref>. Similar levels of undetectable viral load were observed at delivery in a cohort of pregnant women initiated on ART at a median of 20 weeks of gestation in South Africa, <xref rid="jia225376-bib-0010" ref-type="ref">10</xref> and in Malawi <xref rid="jia225376-bib-0019" ref-type="ref">19</xref>, <xref rid="jia225376-bib-0020" ref-type="ref">20</xref>. These data from cohort studies, combined with high levels of viral suppression in centrally located health zones suggest that with increased attention to the quality of care of the kind that is associated with cohort studies (avoidance of stockouts, better training and supervision of providers among others), higher rates of viral suppression can be achieved among pregnant and breastfeeding women in care, no matter the settings. However, even in Southern Africa were over 93% of PWLHIV were estimated to be receiving ART in 2017, estimates of mother‐to‐child transmission still stand around 10% <xref rid="jia225376-bib-0021" ref-type="ref">21</xref>, suggesting similar difficulties as in Kinshasa to achieve and sustained high level of undetectable viral load in routine care settings.</p>
              <p>The issue of high loss‐to‐follow‐up immediately after ART initiation has been at the frontline of PMTCT research, since the start of the option B+ era <xref rid="jia225376-bib-0004" ref-type="ref">4</xref>, <xref rid="jia225376-bib-0015" ref-type="ref">15</xref>, <xref rid="jia225376-bib-0022" ref-type="ref">22</xref>, <xref rid="jia225376-bib-0023" ref-type="ref">23</xref>, <xref rid="jia225376-bib-0024" ref-type="ref">24</xref>. This would implicate that women who are at the highest risk for non‐adherence tend to drop‐out the soonest. Overall, 46% of women in our study had been on ART for &lt;12 months. The proportion of women with viral &lt;1000 or &lt; 40 copies/mL increased from 54% and 44% respectively, among participants who had been on ART for &lt;6 months, to 67% and 60% among those who had been on ART for 12 to 24 months or &gt;24 months and the differences were statistically significant. Similar differences were observed among women tested during pregnancy or in the postpartum period, suggesting the low level of viral suppression is mainly attributable to poor adherence, even in those who have been retained in care for quite some time.</p>
              <p>Over 74% of participants were on TDF/3TC/EFV, a newer regimen that was introduced in this population along with the 2013 WHO recommendation. Yet, the prevalence of detectable viral load or viral load ≥1000 copies/mL did not differ from women on older regimens, mainly AZT/3TC/NVP. Although, we do not have a second viral load to confirm virologic failure <xref rid="jia225376-bib-0013" ref-type="ref">13</xref>, it is particularly concerning to see that a third of participants who had been on ART for ≥12 months had viral load above 1000 copies/mL. In a recent survey of 1064 Cameroonian adults, drug resistance was observed in 63% and 88% of participants with viral load ≥1000 copies/mL and who were on ART between 12 to 24 months and 48 to 60 months respectively <xref rid="jia225376-bib-0025" ref-type="ref">25</xref>. If the same level of drug resistance were to be true in our sample, more than 20% of pregnant and breastfeeding women in care in Kinshasa would have drug resistance to potentially TDF and EFV. These findings support the call from a recent consensus statement on research priorities to inform “treat all” implementation in sub‐Saharan Africa for research to estimate the incidence and prevalence of drug resistance <xref rid="jia225376-bib-0026" ref-type="ref">26</xref>.</p>
              <p>The usual clinic and socio‐demographic characteristics known to be associated with retention in care and adherence were also associated with higher viral suppression in our population. At the individual level, being married or cohabiting, not walking to the clinic, disclosure of HIV status were all positively associated with viral suppression <xref rid="jia225376-bib-0027" ref-type="ref">27</xref>, <xref rid="jia225376-bib-0028" ref-type="ref">28</xref>, <xref rid="jia225376-bib-0029" ref-type="ref">29</xref>. Nonetheless, our finding in that disclosure of HIV status to anyone might negatively affect viral suppression in breastfeeding women warrants further investigations. Emerging data from South Africa suggest that disclosure is not always universally positive and may depend on the person to whom the status is disclosed to <xref rid="jia225376-bib-0030" ref-type="ref">30</xref>, <xref rid="jia225376-bib-0031" ref-type="ref">31</xref>.</p>
              <p>At the facility level, receiving care in a hospital, in an urban area, or in a PEPFAR‐supported facility were all positively associated with viral suppression, particularly at delivery and in the postpartum period, reflecting the possible higher degree of proficiency among clinics that receive technical support from PEPFAR implementing partners <xref rid="jia225376-bib-0032" ref-type="ref">32</xref>, <xref rid="jia225376-bib-0033" ref-type="ref">33</xref>. However, selection of clinics supported by PEPFAR was not done randomly and because of the cross‐sectional design of the study, it is not possible to ascertain whether this association is a result of PEPFAR selecting clinics that are known to have the capacity to deliver better HIV care or the result of additional technical support to these clinics. Stockouts of HIV commodities including ART are common in health facilities across Kinshasa even when such commodities are available at local upstream warehouses <xref rid="jia225376-bib-0034" ref-type="ref">34</xref>. It is possible that the additional support from PEPFAR, through regular supervision is effective in reducing the impact of such stockouts on ART adherence.</p>
              <p>Selection of clinics was based on their size as opposed to probability sampling, meaning that our sample may not be representative of all PWLHIV in the province. However, because all 35 health zones in the Kinshasa province were represented and virtually all women receiving ART care in these clinics were enrolled, our results apply to the vast majority of women in care in the province. The study has additional limitations. First, because of the cross‐sectional nature of the design, we do not have a second sample from participants to confirm viral failure among those with viral load ≥1000 copies/mL. Similarly, drug resistance testing was not planned in the study and is not routinely available in Kinshasa. Confirming viral failure and estimating the level of drug resistance in this population is urgently needed to inform choice of treatment regimen for both pregnant and breastfeeding women in DRC and their HIV‐positive infants. In addition, because of the cross‐sectional design we were also unable to account for selective drop‐out of potentially non‐adherent women. Second, few eligible participants either did not agree to provide a blood sample for viral load testing, or the sample was not properly collected or handled. However, given that virtually none of the women knew their viral load at the time, it is unlikely that inclusion in this analysis was related to actual value of viral load. Third, we did not collect data on drug stockouts during the study. It is possible that many of the women with unsuppressed viral load were simply not taking any medication at the time of the blood collection <xref rid="jia225376-bib-0034" ref-type="ref">34</xref>. Fourth, as mentioned earlier, DBS viral load systematically underestimates plasma viral load <xref rid="jia225376-bib-0018" ref-type="ref">18</xref>, suggesting that the true proportion of women with viral load ≥1000 copies/mL is likely underestimated.</p>
            </sec>
            <sec id="jia225376-sec-0017">
              <label>5</label>
              <title>Conclusions</title>
              <p>Close to half of pregnant and breastfeeding women receiving ART care in MCH clinics in Kinshasa, had detectable viral load. Even among women who had been on ART for longer than 12 months, at least a third had viral load ≥1000 copies/mL suggesting a potential high level of drug resistance that needs to be urgently investigated. The observed high level of detectable viral load suggests that high ART coverage alone without substantial efforts to improve the quality of care for pregnant and breastfeeding women, will not be enough to achieve the goal of virtual elimination of vertical HIV transmission in high‐burden and limited resources settings like DRC.</p>
            </sec>
            <sec id="jia225376-sec-0018">
              <title>Competing interests</title>
              <p>No author had a competing interest to declare.</p>
            </sec>
            <sec id="jia225376-sec-0019">
              <title>Authors’ contributions</title>
              <p>MY, FB and EO conceptualized the study and acquired funding. CM, MT, NLRR, FM, BK, EO and MY acquired the data. CM and MY performed data analysis and drafted the first manuscript version. All authors read and approved the final manuscript.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="jia225376-sup-0001">
                <caption>
                  <p><bold>Table S1.</bold> Bivariable associations between facilities’, socio‐demographic and clinical characteristics and viral load &lt;40 copies/mL by timing of HIV viral load testing<sup>a</sup>
</p>
                  <p><bold>Table S2.</bold> Multivariable associations between facility characteristics, socio‐demographic and clinical characteristics of 1623 women tested for HIV viral load in 105 clinics in Kinshasa between November 2016 and July 2018 and viral load &lt;40 copies/mL, stratified by timing of viral load testing<sup>a</sup>
</p>
                  <p><bold>Table S3.</bold> Prevalence of VL&lt;1000 copies/mL and VL&lt;40 cp/mL by health zone in Kinshasa. Democratic Republic of Congo</p>
                </caption>
                <media xlink:href="JIA2-22-e25376-s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="jia225376-sec-0020">
              <title>Acknowledgements</title>
              <p>We thank all the women who contributed to the findings of this study. We acknowledge the contribution of the following site investigators of the CQI‐PMTCT study team: Godelive Aitikalema, Ali Alisho, Elysée Bayayana, Fabrice Bumwana, Pierre Dianzenza, Jean Claude Dinanga, Georges Kihuma, Willy Lukumu, Fidèle Lumande, Zouzou Masevo, Fanny Matadi, Rachel Mushiya, Marie Therèse Mwela, José Nlandu, Pearl Tenatena and Marie Tshibuabua. We are grateful to the staff of the participating clinics, and to the provincial and national health authorities. We also acknowledge the support we received from the administrative staff of the Ohio State University and the Kinshasa School of Public Health.</p>
              <sec id="jia225376-sec-0021">
                <title>Funding</title>
                <p>This research was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) and the National Institute of Health and Child Development (NIHCD 1R01H087993). MY and CM are partially supported by the National Institutes of Health (NIAID U01AI096299). The funders had no role in study design, data collection, data analysis and interpretation, preparation of the manuscript, or decision to submit.</p>
              </sec>
            </ack>
            <ref-list content-type="cited-references" id="jia225376-bibl-0001">
              <title>References</title>
              <ref id="jia225376-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="miscellaneous" id="jia225376-cit-0001"><collab collab-type="authors">UNAIDS</collab>
. <article-title>On the fast‐track to an AIDS free generation</article-title>. <year>2016</year>.</mixed-citation>
              </ref>
              <ref id="jia225376-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="miscellaneous" id="jia225376-cit-0002"><collab collab-type="authors">UNAIDS</collab>
. <article-title>Start Free, Stay Free, AIDS Free: a super fast‐track framework for ending aids in children, adolescents, and young women by 2020</article-title>. <year>2016</year>.</mixed-citation>
              </ref>
              <ref id="jia225376-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="miscellaneous" id="jia225376-cit-0003"><collab collab-type="authors">UNAIDS</collab>
. <article-title>Start free, stay free, AIDS free: 2017 progress report</article-title>. <year>2017</year>.</mixed-citation>
              </ref>
              <ref id="jia225376-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0004"><string-name><surname>Abuogi</surname><given-names>LL</given-names></string-name>, <string-name><surname>Humphrey</surname><given-names>JM</given-names></string-name>, <string-name><surname>Mpody</surname><given-names>C</given-names></string-name>, <string-name><surname>Yotebieng</surname><given-names>M</given-names></string-name>, <string-name><surname>Murnane</surname><given-names>PM</given-names></string-name>, <string-name><surname>Clouse</surname><given-names>K</given-names></string-name>, et al. <article-title>Achieving UNAIDS 90‐90‐90 targets for pregnant and postpartum women in sub‐Saharan Africa: progress, gaps and research needs</article-title>. <source xml:lang="en">J Virus Erad</source>. <year>2018</year>;<volume>4</volume>
<issue>Supplement 2</issue>:<fpage>33</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">30515312</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0005"><string-name><surname>Knettel</surname><given-names>BA</given-names></string-name>, <string-name><surname>Cichowitz</surname><given-names>C</given-names></string-name>, <string-name><surname>Ngocho</surname><given-names>JS</given-names></string-name>, <string-name><surname>Knippler</surname><given-names>ET</given-names></string-name>, <string-name><surname>Chumba</surname><given-names>LN</given-names></string-name>, <string-name><surname>Mmbaga</surname><given-names>BT</given-names></string-name>, et al. <article-title>Retention in HIV care during pregnancy and the postpartum period in the option B+ era: systematic review and meta‐analysis of studies in Africa</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2018</year>;<volume>77</volume>(<issue>5</issue>):<fpage>427</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">29287029</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0006"><string-name><surname>Myer</surname><given-names>L</given-names></string-name>, <string-name><surname>Dunning</surname><given-names>L</given-names></string-name>, <string-name><surname>Lesosky</surname><given-names>M</given-names></string-name>, <string-name><surname>Hsiao</surname><given-names>NY</given-names></string-name>, <string-name><surname>Phillips</surname><given-names>T</given-names></string-name>, <string-name><surname>Petro</surname><given-names>G</given-names></string-name>, et al. <article-title>Frequency of viremic episodes in HIV‐infected women initiating antiretroviral therapy during pregnancy: a cohort study</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2017</year>;<volume>64</volume>(<issue>4</issue>):<fpage>422</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">27927852</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0007"><string-name><surname>Yotebieng</surname><given-names>M</given-names></string-name>, <string-name><surname>Thirumurthy</surname><given-names>H</given-names></string-name>, <string-name><surname>Moracco</surname><given-names>KE</given-names></string-name>, <string-name><surname>Edmonds</surname><given-names>A</given-names></string-name>, <string-name><surname>Tabala</surname><given-names>M</given-names></string-name>, <string-name><surname>Kawende</surname><given-names>B</given-names></string-name>, et al. <article-title>Conditional cash transfers to increase retention in PMTCT care, antiretroviral adherence, and postpartum virological suppression: a randomized controlled trial</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2016</year>;<volume>72</volume>
<issue>Suppl 2</issue>:<fpage>S124</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">27355499</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0008"><string-name><surname>Nachega</surname><given-names>JB</given-names></string-name>, <string-name><surname>Uthman</surname><given-names>OA</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>J</given-names></string-name>, <string-name><surname>Peltzer</surname><given-names>K</given-names></string-name>, <string-name><surname>Wampold</surname><given-names>S</given-names></string-name>, <string-name><surname>Cotton</surname><given-names>MF</given-names></string-name>, et al. <article-title>Adherence to antiretroviral therapy during and after pregnancy in low‐income, middle‐income, and high‐income countries: a systematic review and meta‐analysis</article-title>. <source xml:lang="en">AIDS</source>. <year>2012</year>;<volume>26</volume>(<issue>16</issue>):<fpage>2039</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">22951634</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0009"><string-name><surname>Haas</surname><given-names>AD</given-names></string-name>, <string-name><surname>Msukwa</surname><given-names>MT</given-names></string-name>, <string-name><surname>Egger</surname><given-names>M</given-names></string-name>, <string-name><surname>Tenthani</surname><given-names>L</given-names></string-name>, <string-name><surname>Tweya</surname><given-names>H</given-names></string-name>, <string-name><surname>Jahn</surname><given-names>A</given-names></string-name>, et al. <article-title>Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving care in Malawi's option B+ program</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2016</year>;<volume>63</volume>(<issue>9</issue>):<fpage>1227</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="pmid">27461920</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0010"><string-name><surname>Myer</surname><given-names>L</given-names></string-name>, <string-name><surname>Phillips</surname><given-names>TK</given-names></string-name>, <string-name><surname>McIntyre</surname><given-names>JA</given-names></string-name>, <string-name><surname>Hsiao</surname><given-names>NY</given-names></string-name>, <string-name><surname>Petro</surname><given-names>G</given-names></string-name>, <string-name><surname>Zerbe</surname><given-names>A</given-names></string-name>, et al. <article-title>HIV viraemia and mother‐to‐child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa</article-title>. <source xml:lang="en">HIV Med</source>. <year>2017</year>;<volume>18</volume>(<issue>2</issue>):<fpage>80</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="pmid">27353189</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0011"><string-name><surname>Yotebieng</surname><given-names>M</given-names></string-name>, <string-name><surname>Behets</surname><given-names>F</given-names></string-name>, <string-name><surname>Kawende</surname><given-names>B</given-names></string-name>, <string-name><surname>Ravelomanana</surname><given-names>NL</given-names></string-name>, <string-name><surname>Tabala</surname><given-names>M</given-names></string-name>, <string-name><surname>Okitolonda</surname><given-names>EW</given-names></string-name>. <article-title>Continuous quality improvement interventions to improve long‐term outcomes of antiretroviral therapy in women who initiated therapy during pregnancy or breastfeeding in the Democratic Republic of Congo: design of an open‐label, parallel, group randomized trial</article-title>. <source xml:lang="en">BMC Health Serv Res</source>. <year>2017</year>;<volume>17</volume>(<issue>1</issue>):<fpage>306</fpage>.<pub-id pub-id-type="pmid">28446232</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="book" id="jia225376-cit-0012"><collab collab-type="authors">International, M.d.P.e.M</collab>
. <article-title>Démographique et de Santé, République Démocratique du Congo 2013‐1014: Rapport Préliminaire sur la Prévalence du VIH</article-title>. <publisher-loc>Calverton, MD</publisher-loc>: <publisher-name>Ministère du Plan et Macro International</publisher-name>; <year>2014</year>.</mixed-citation>
              </ref>
              <ref id="jia225376-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="book" id="jia225376-cit-0013"><collab collab-type="authors">World Health Organization</collab>
. <article-title>Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach</article-title>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2013</year>.</mixed-citation>
              </ref>
              <ref id="jia225376-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0014"><string-name><surname>Boillot</surname><given-names>F</given-names></string-name>, <string-name><surname>Serrano</surname><given-names>L</given-names></string-name>, <string-name><surname>Muwonga</surname><given-names>J</given-names></string-name>, <string-name><surname>Kabuayi</surname><given-names>JP</given-names></string-name>, <string-name><surname>Kambale</surname><given-names>A</given-names></string-name>, <string-name><surname>Mutaka</surname><given-names>F</given-names></string-name>, et al. <article-title>Implementation and operational research: programmatic feasibility of dried blood spots for the virological follow‐up of patients on antiretroviral treatment in NORD KIVU, Democratic Republic of the Congo</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2016</year>;<volume>71</volume>:<fpage>e9</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="pmid">26413848</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0015"><string-name><surname>Yotebieng</surname><given-names>M</given-names></string-name>, <string-name><surname>Thirumurthy</surname><given-names>H</given-names></string-name>, <string-name><surname>Moracco</surname><given-names>KE</given-names></string-name>, <string-name><surname>Kawende</surname><given-names>B</given-names></string-name>, <string-name><surname>Chalachala</surname><given-names>JL</given-names></string-name>, <string-name><surname>Wenzi</surname><given-names>LK</given-names></string-name>, et al. <article-title>Conditional cash transfers and uptake of and retention in prevention of mother‐to‐child HIV transmission care: a randomised controlled trial</article-title>. <source xml:lang="en">Lancet HIV</source>. <year>2016</year>;<volume>3</volume>:<fpage>e85</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="pmid">26847230</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0016"><string-name><surname>Yotebieng</surname><given-names>M</given-names></string-name>, <string-name><surname>Labbok</surname><given-names>M</given-names></string-name>, <string-name><surname>Soeters</surname><given-names>HM</given-names></string-name>, <string-name><surname>Chalachala</surname><given-names>JL</given-names></string-name>, <string-name><surname>Lapika</surname><given-names>B</given-names></string-name>, <string-name><surname>Vitta</surname><given-names>BS</given-names></string-name>, et al. <article-title>Ten Steps to Successful Breastfeeding programme to promote early initiation and exclusive breastfeeding in DR Congo: a cluster‐randomised controlled trial</article-title>. <source xml:lang="en">Lancet Glob Health</source>. <year>2015</year>;<volume>3</volume>:<fpage>e546</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">26246225</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0017"><string-name><surname>Maldonado</surname><given-names>G</given-names></string-name>, <string-name><surname>Greenland</surname><given-names>S</given-names></string-name>. <article-title>Simulation study of confounder‐selection strategies</article-title>. <source xml:lang="en">Am J Epidemiol</source>. <year>1993</year>;<volume>138</volume>(<issue>11</issue>):<fpage>923</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">8256780</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0018"><string-name><surname>Pannus</surname><given-names>P</given-names></string-name>, <string-name><surname>Claus</surname><given-names>M</given-names></string-name>, <string-name><surname>Gonzalez</surname><given-names>MM</given-names></string-name>, <string-name><surname>Ford</surname><given-names>N</given-names></string-name>, <string-name><surname>Fransen</surname><given-names>K</given-names></string-name>.<article-title>Sensitivity and specificity of dried blood spots for HIV‐1 viral load quantification: a laboratory assessment of 3 commercial assays</article-title>. <source xml:lang="en">Medicine (Baltimore)</source>. <year>2016</year>;<volume>95</volume>:<elocation-id>e5475</elocation-id>.<pub-id pub-id-type="pmid">27902602</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0019"><string-name><surname>Chagomerana</surname><given-names>MB</given-names></string-name>, <string-name><surname>Miller</surname><given-names>WC</given-names></string-name>, <string-name><surname>Tang</surname><given-names>JH</given-names></string-name>, <string-name><surname>Hoffman</surname><given-names>IF</given-names></string-name>, <string-name><surname>Mthiko</surname><given-names>BC</given-names></string-name>, <string-name><surname>Phulusa</surname><given-names>J</given-names></string-name>, et al. <article-title>Optimizing prevention of HIV mother to child transmission: duration of antiretroviral therapy and viral suppression at delivery among pregnant Malawian women</article-title>. <source xml:lang="en">PLoS One</source>. <year>2018</year>;<volume>13</volume>:<elocation-id>e0195033</elocation-id>.<pub-id pub-id-type="pmid">29614083</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0020"><string-name><surname>Hosseinipour</surname><given-names>M</given-names></string-name>, <string-name><surname>Nelson</surname><given-names>JAE</given-names></string-name>, <string-name><surname>Trapence</surname><given-names>C</given-names></string-name>, <string-name><surname>Rutstein</surname><given-names>SE</given-names></string-name>, <string-name><surname>Kasende</surname><given-names>F</given-names></string-name>, , <string-name><surname>Kayoyo</surname><given-names>V</given-names></string-name>, et al. <article-title>Viral suppression and HIV drug resistance at 6 months among women in Malawi's option B+ program: results from the PURE Malawi study</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2017</year>;<volume>75</volume>
<issue>Suppl 2</issue>:<fpage>S149</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="pmid">28498184</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="book" id="jia225376-cit-0021"><collab collab-type="authors">UNAIDS</collab>
. <article-title>Global AIDS update 2018: Miles to go – closing gaps, breaking barriers, righting injustices</article-title>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>Joint United Nations Programme on HIV/AIDS (UNAIDS)</publisher-name>; <year>2018</year>.</mixed-citation>
              </ref>
              <ref id="jia225376-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0022"><string-name><surname>Yotebieng</surname><given-names>M</given-names></string-name>, <string-name><surname>Moracco</surname><given-names>KE</given-names></string-name>, <string-name><surname>Thirumurthy</surname><given-names>H</given-names></string-name>, <string-name><surname>Edmonds</surname><given-names>A</given-names></string-name>, <string-name><surname>Tabala</surname><given-names>M</given-names></string-name>, <string-name><surname>Kawende</surname><given-names>B</given-names></string-name>, et al. <article-title>Conditional cash transfers improve retention in PMTCT services by mitigating the negative effect of not having money to come to the clinic</article-title>. <source xml:lang="en">J Acquir Immune Defic Syndr</source>. <year>2017</year>;<volume>74</volume>(<issue>2</issue>):<fpage>150</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">27787342</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0023"><string-name><surname>Ross</surname><given-names>J</given-names></string-name>, <string-name><surname>Edmonds</surname><given-names>A</given-names></string-name>, <string-name><surname>Hoover</surname><given-names>DR</given-names></string-name>, <string-name><surname>Shi</surname><given-names>Q</given-names></string-name>, <string-name><surname>Anastos</surname><given-names>K</given-names></string-name>, <string-name><surname>Lelo</surname><given-names>P</given-names></string-name>, et al. <article-title>Association between pregnancy at enrollment into HIV care and loss to care among women in the Democratic Republic of Congo, 2006‐2013</article-title>. <source xml:lang="en">PLoS One</source>. <year>2018</year>;<volume>13</volume>:<elocation-id>e0195231</elocation-id>.<pub-id pub-id-type="pmid">29608618</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0024"><string-name><surname>Gichane</surname><given-names>MW</given-names></string-name>, <string-name><surname>Moracco</surname><given-names>KE</given-names></string-name>, <string-name><surname>Thirumurthy</surname><given-names>H</given-names></string-name>, <string-name><surname>Okitolonda</surname><given-names>EW</given-names></string-name>, <string-name><surname>Behets</surname><given-names>F</given-names></string-name>, <string-name><surname>Yotebieng</surname><given-names>M</given-names></string-name><article-title>Intimate partner violence and prevention of mother to child transmission of HIV: evidence from Kinshasa, Democratic Republic of Congo</article-title>. <source xml:lang="en">PLoS One</source>. <year>2018</year>;<volume>13</volume>:<elocation-id>e0203471</elocation-id>.<pub-id pub-id-type="pmid">30161260</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0025"><string-name><surname>Tchouwa</surname><given-names>GF</given-names></string-name>, <string-name><surname>Eymard‐Duvernay</surname><given-names>S</given-names></string-name>, <string-name><surname>Cournil</surname><given-names>A</given-names></string-name>, <string-name><surname>Lamare</surname><given-names>N</given-names></string-name>, <string-name><surname>Serrano</surname><given-names>L</given-names></string-name>, <string-name><surname>Butel</surname><given-names>C</given-names></string-name>, et al. <article-title>Nationwide estimates of viral load suppression and acquired HIV drug resistance in cameroon</article-title>. <source xml:lang="en">EClinicalMedicine</source>. <year>2018</year>;<volume>1</volume>:<fpage>21</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">31193678</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0026"><string-name><surname>Yotebieng</surname><given-names>M</given-names></string-name>, <string-name><surname>Brazier</surname><given-names>E</given-names></string-name>, <string-name><surname>Addison</surname><given-names>D</given-names></string-name>, <string-name><surname>Kimmel</surname><given-names>AD</given-names></string-name>, <string-name><surname>Cornell</surname><given-names>M</given-names></string-name>, <string-name><surname>Keiser</surname><given-names>O</given-names></string-name>, et al. <article-title>Research priorities to inform “Treat All” policy implementation for people living with HIV in sub‐Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA)</article-title>. <source xml:lang="en">J Int AIDS Soc</source>. <year>2019</year>;<volume>22</volume>:<elocation-id>e25218</elocation-id>.<pub-id pub-id-type="pmid">30657644</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0027"><string-name><surname>Gill</surname><given-names>MM</given-names></string-name>, <string-name><surname>Hoffman</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Bobrow</surname><given-names>EA</given-names></string-name>, <string-name><surname>Mugwaneza</surname><given-names>P</given-names></string-name>, <string-name><surname>Ndatimana</surname><given-names>D</given-names></string-name>, <string-name><surname>Ndayisaba</surname><given-names>GF</given-names></string-name>, et al. <article-title>Detectable viral load in late pregnancy among women in the rwanda option B plus PMTCT program: enrollment results from the Kabeho Study</article-title>. <source xml:lang="en">PLoS One</source>. <year>2016</year>;<volume>11</volume>:<elocation-id>e0168671</elocation-id>.<pub-id pub-id-type="pmid">28006001</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0028"><string-name><surname>Labhardt</surname><given-names>ND</given-names></string-name>, <string-name><surname>Bader</surname><given-names>J</given-names></string-name>, <string-name><surname>Ramoeletsi</surname><given-names>M</given-names></string-name>, <string-name><surname>Kamele</surname><given-names>M</given-names></string-name>, <string-name><surname>Lejone</surname><given-names>TI</given-names></string-name>, <string-name><surname>Cheleboi</surname><given-names>M</given-names></string-name>, et al. <article-title>Clinical and socio‐demographic predictors for virologic failure in rural Southern Africa: preliminary findings from CART‐1</article-title>. <source xml:lang="en">J Int AIDS Soc</source>. <year>2014</year>;<volume>17</volume>:<fpage>115</fpage>–<lpage>6</lpage>.</mixed-citation>
              </ref>
              <ref id="jia225376-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0029"><string-name><surname>Jasseron</surname><given-names>C</given-names></string-name>, <string-name><surname>Mandelbrot</surname><given-names>L</given-names></string-name>, <string-name><surname>Dollfus</surname><given-names>C</given-names></string-name><string-name><surname>Trocmé</surname><given-names>N</given-names></string-name>, <string-name><surname>Tubiana</surname><given-names>R</given-names></string-name>, <string-name><surname>Teglas</surname><given-names>JP</given-names></string-name>, et al. <article-title>Non‐disclosure of a pregnant woman's HIV status to her partner is associated with non‐optimal prevention of mother‐to‐child transmission</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2013</year>;<volume>17</volume>(<issue>2</issue>):<fpage>488</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">22130651</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0030"><string-name><surname>Brittain</surname><given-names>K</given-names></string-name>, <string-name><surname>Mellins</surname><given-names>CA</given-names></string-name>, <string-name><surname>Remien</surname><given-names>RH</given-names></string-name>, <string-name><surname>Phillips</surname><given-names>T</given-names></string-name>, <string-name><surname>Zerbe</surname><given-names>A</given-names></string-name>, <string-name><surname>Abrams</surname><given-names>EJ</given-names></string-name>, et al. <article-title>Patterns and predictors of HIV‐status disclosure among pregnant women in South Africa: dimensions of disclosure and influence of social and economic circumstances</article-title>. <source xml:lang="en">AIDS Behav</source>. <year>2018</year>;<volume>22</volume>(<issue>12</issue>):<fpage>3933</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">30155586</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0031"><string-name><surname>Hunter‐Adams</surname><given-names>J</given-names></string-name>, <string-name><surname>Zerbe</surname><given-names>A</given-names></string-name>, <string-name><surname>Philips</surname><given-names>T</given-names></string-name>, <string-name><surname>Rini</surname><given-names>Z</given-names></string-name>, <string-name><surname>Myer</surname><given-names>L</given-names></string-name>, <string-name><surname>Petro</surname><given-names>G</given-names></string-name>, et al. <article-title>The dimensionality of disclosure of HIV status amongst post‐partum women in Cape Town, South Africa</article-title>. <source xml:lang="en">Afr J AIDS Res</source>. <year>2017</year>;<volume>16</volume>(<issue>2</issue>):<fpage>101</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">28565973</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0032"><string-name><surname>Duda</surname><given-names>SN</given-names></string-name>, <string-name><surname>Farr</surname><given-names>AM</given-names></string-name>, <string-name><surname>Lindegren</surname><given-names>ML</given-names></string-name>, <string-name><surname>Blevins</surname><given-names>M</given-names></string-name>, <string-name><surname>Wester</surname><given-names>CW</given-names></string-name>, <string-name><surname>Wools‐Kaloustian</surname><given-names>K</given-names></string-name>, et al. <article-title>Characteristics and comprehensiveness of adult HIV care and treatment programmes in Asia‐Pacific, sub‐Saharan Africa and the Americas: results of a site assessment conducted by the International epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration</article-title>. <source xml:lang="en">J Int AIDS Soc</source>. <year>2014</year>;<volume>17</volume>:<fpage>19045</fpage>.<pub-id pub-id-type="pmid">25516092</pub-id></mixed-citation>
              </ref>
              <ref id="jia225376-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0033"><string-name><surname>Fritz</surname><given-names>CQ</given-names></string-name>, <string-name><surname>Blevins</surname><given-names>M</given-names></string-name>, <string-name><surname>Lindegren</surname><given-names>ML</given-names></string-name>, <string-name><surname>Wools‐Kaloutsian</surname><given-names>K</given-names></string-name>, <string-name><surname>Musick</surname><given-names>BS</given-names></string-name>, <string-name><surname>Cornell</surname><given-names>M</given-names></string-name>, et al. <article-title>Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014</article-title>. <source xml:lang="en">J Int AIDS Soc</source>. <year>2017</year>;<volume>20</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation>
              </ref>
              <ref id="jia225376-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="jia225376-cit-0034"><string-name><surname>Gils</surname><given-names>T</given-names></string-name>, <string-name><surname>Bossard</surname><given-names>C</given-names></string-name>, <string-name><surname>Verdonck</surname><given-names>K</given-names></string-name>, <string-name><surname>Owiti</surname><given-names>P</given-names></string-name>, <string-name><surname>Casteels</surname><given-names>I</given-names></string-name>, <string-name><surname>Mashako</surname><given-names>M</given-names></string-name>, et al. <article-title>Stockouts of HIV commodities in public health facilities in Kinshasa: barriers to end HIV</article-title>. <source xml:lang="en">PLoS One</source>. <year>2018</year>;<volume>13</volume>:<elocation-id>e0191294</elocation-id>.<pub-id pub-id-type="pmid">29351338</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
